Atrium Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
14
across all filing types
Latest filing
2026-05-15
Major Shareholding Noti…
Country
US
United States of America
Listing
—
RNA
Atrium Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering precision RNA medicines for cardiac diseases. The company develops and delivers targeted RNA therapeutics directly to the heart, aiming to transform the standard of care for patients with rare, life-threatening genetic cardiomyopathies. Its initial focus includes PLN cardiomyopathy and PRKAG2 Syndrome, conditions characterized by high unmet medical need and a lack of approved treatment options. This approach seeks to provide novel therapeutic solutions by delivering RNA medicines to hard-to-reach cardiac muscle tissue.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Major Shareholding Notification 2026 | 2026-05-15 | English | |
| 10-Q | 2026-05-14 | English | |
| 8-K | 2026-05-14 | English | |
| Major Shareholding Notification 2026 | 2026-04-27 | English | |
| S-8 | 2026-04-17 | English | |
| Major Shareholding Notification 2026 | 2026-04-08 | English |
Browse filings by year
2 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 46725131 | Major Shareholding Notification 2026 | 2026-05-15 | English | ||
| 46725128 | 10-Q | 2026-05-14 | English | ||
| 46725129 | 8-K | 2026-05-14 | English | ||
| 46725133 | Major Shareholding Notification 2026 | 2026-04-27 | English | ||
| 46725136 | S-8 | 2026-04-17 | English | ||
| 46725137 | Major Shareholding Notification 2026 | 2026-04-08 | English | ||
| 46725141 | 8-K | 2026-02-27 | English | ||
| 46725142 | 8-K | 2026-02-26 | English | ||
| 46725146 | S-8 | 2026-02-26 | English | ||
| 46725147 | Regulatory Filings 2026 | 2026-02-26 | English | ||
| 46725148 | Regulatory Filings 2026 | 2026-02-26 | English | ||
| 46725151 | 10-12B/A | 2026-02-17 | English | ||
| 46725154 | 10-12B/A | 2026-01-30 | English | ||
|
2025
1 filing
| |||||
| 46725156 | 10-12B | 2025-12-10 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Enervit
Develops sports nutrition, functional foods, and wellness s…
|
ENV | IT | Manufacturing |
|
enGene Holdings Inc.
Clinical-stage biotech developing non-viral gene therapies …
|
ENGN | CA | Manufacturing |
|
Enliven Therapeutics, Inc.
Clinical-stage biopharma developing kinase inhibitors for p…
|
ELVN | US | Manufacturing |
|
Enlivex Therapeutics Ltd.
A clinical-stage macrophage reprogramming immunotherapy com…
|
ENLV | IL | Manufacturing |
|
Enlivex Therapeutics Ltd.
Develops macrophage reprogramming immunotherapy for inflamm…
|
ENLV | US | Manufacturing |
|
Enorama Pharma AB
Develops and manufactures medicated chewing gums and tobacc…
|
ERMA | SE | Manufacturing |
|
Ensol Biosciences Inc.
AI-driven biopharma developing peptide drugs for unmet medi…
|
140610 | KR | Manufacturing |
|
Entera Bio Ltd.
A clinical-stage company developing oral peptide and protei…
|
ENTX | IL | Manufacturing |
|
Entero Therapeutics, Inc.
Clinical-stage biopharma developing oral therapies for gast…
|
ENTO | US | Manufacturing |
|
Entourage Health Corp.
Licensed cannabis producer serving medical, recreational, a…
|
ENTG | CA | Manufacturing |
Atrium Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/72608/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=72608 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=72608 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=72608 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 72608}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Atrium Therapeutics, Inc. (id: 72608)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.